This inventor holds 5 USPTO granted patents. Top assignee: Nissan Chemical Industries Limited. Active years: 1998-2006.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Funabashi, JP (1998 - 2001)
- Chiba, JP (2006)
Company Filing History:
Years Active: 1998-2006
Title: Kenichi Tokunaga: Innovator in Pharmaceutical Chemistry
Introduction
Kenichi Tokunaga is a prominent inventor based in Funabashi, Japan. He has made significant contributions to the field of pharmaceutical chemistry, holding a total of 5 patents. His work focuses on innovative methods for synthesizing important chemical compounds used in pharmaceuticals.
Latest Patents
One of his latest patents is a method for preparing a 7-quinolinyl-3,5-dihydroxyhept-6-enoate. This method is particularly useful as an intermediate for pharmaceuticals, allowing for high yield and high purity. The process involves reducing a specific compound using sodium borohydride in the presence of a boron compound, followed by treatment with an aqueous solution of hydrogen peroxide. Another notable patent relates to the preparation of 4,6-diaminoresorcinol or its salts, achieved by reducing 4,6-bis(substituted)phenylazoresorcinol.
Career Highlights
Kenichi Tokunaga is associated with Nissan Chemical Industries Limited, where he has been instrumental in advancing chemical processes that benefit the pharmaceutical industry. His innovative approaches have garnered attention and respect within the scientific community.
Collaborations
Throughout his career, Tokunaga has collaborated with esteemed colleagues, including Isao Hashiba and Hideo Suzuki. These partnerships have further enhanced his research and development efforts in the field.
Conclusion
Kenichi Tokunaga's contributions to pharmaceutical chemistry through his innovative patents and collaborations highlight his role as a key inventor in the industry. His work continues to influence the development of important pharmaceutical compounds.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile